microRNAs in Gliomas: Small Regulators of a Big Problem

[1]  Y. Chen,et al.  miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  T. Kondoh,et al.  MicroRNA‐10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC , 2009, International journal of cancer.

[3]  K. Aldape,et al.  Beyond grade: molecular pathology of malignant gliomas. , 2009, Seminars in radiation oncology.

[4]  P. Sun,et al.  MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. , 2009, Biochemical and biophysical research communications.

[5]  Hai Yan,et al.  Glioblastoma multiforme: a review of therapeutic targets , 2009, Expert opinion on therapeutic targets.

[6]  A. Argyriou,et al.  Angiogenesis and Anti-Angiogenic Molecularly Targeted Therapies in Malignant Gliomas , 2009, Oncology.

[7]  H. Kung,et al.  microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs , 2009, Brain Research.

[8]  Michael T. McManus,et al.  Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion* , 2009, The Journal of Biological Chemistry.

[9]  Xu Ma,et al.  MiR-125b Expression Affects the Proliferation and Apoptosis of Human Glioma Cells by Targeting Bmf , 2009, Cellular Physiology and Biochemistry.

[10]  S. Vatner,et al.  Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes , 2009, Circulation research.

[11]  S. Niclou,et al.  Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms , 2009, Expert opinion on therapeutic targets.

[12]  X. Chen,et al.  Role of miR-143 targeting KRAS in colorectal tumorigenesis , 2009, Oncogene.

[13]  Yi Tie,et al.  miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. , 2009, Cancer letters.

[14]  H. Kung,et al.  MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. , 2009, Biochemical and biophysical research communications.

[15]  Carla Oliveira,et al.  A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function , 2009, Nature Genetics.

[16]  John S Mattick,et al.  Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.

[17]  S. Baker,et al.  PTEN and the PI3-kinase pathway in cancer. , 2009, Annual review of pathology.

[18]  Francesco Tomasello,et al.  miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors , 2009, Journal of Neuro-Oncology.

[19]  Arturo Alvarez-Buylla,et al.  Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. , 2009, Cancer cell.

[20]  Jan-Fang Cheng,et al.  Dicer, Drosha, and outcomes in patients with ovarian cancer. , 2008, The New England journal of medicine.

[21]  Wei Liu,et al.  MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. , 2008, Cancer letters.

[22]  K. Stankunas,et al.  Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126 , 2008, Development.

[23]  Christiane Haffner,et al.  miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex , 2008, Development.

[24]  Agnieszka Bronisz,et al.  Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.

[25]  R. Weissleder,et al.  miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. , 2008, Cancer cell.

[26]  Junxia Zhang,et al.  hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells , 2008, Brain Research.

[27]  K. Ohshiro,et al.  MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. , 2008, Cancer research.

[28]  Kishore Guda,et al.  The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers , 2008, Genes, chromosomes & cancer.

[29]  Alice Shapiro,et al.  MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. , 2008, Cancer research.

[30]  Hailong Wu,et al.  Suppression of cell growth and invasion by miR-205 in breast cancer , 2008, Cell Research.

[31]  Scott A Gerber,et al.  Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis , 2008, Proceedings of the National Academy of Sciences.

[32]  Robert Blelloch,et al.  Embryonic Stem Cell Specific MicroRNAs Regulate the G1/S Transition and Promote Rapid Proliferation , 2008, Nature Genetics.

[33]  C. James,et al.  Stem cells for treating glioblastoma: how close to reality? , 2008, Neuro-oncology.

[34]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[35]  K. Yanagisawa,et al.  Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. , 2008, Cancer research.

[36]  M. Turunen,et al.  Hypoxia induces microRNA miR‐210 in vitro and in vivo , 2008, FEBS letters.

[37]  T. Wurdinger,et al.  MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators , 2008, Molecular and Cellular Biology.

[38]  S. Vandenberg,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. , 2008 .

[39]  Fabio Martelli,et al.  MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3* , 2008, Journal of Biological Chemistry.

[40]  S. Vandenberg,et al.  Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. , 2008, Neuro-oncology.

[41]  Yunqing Li,et al.  microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. , 2008, Cancer research.

[42]  Osamu Yoshino,et al.  Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. , 2008, The Journal of clinical investigation.

[43]  S. K. Zaidi,et al.  MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. , 2008, Cancer research.

[44]  R. Bernards,et al.  Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.

[45]  K. Lamborn,et al.  Neuro-oncology New Therapeutic Approach for Brain Tumors: Intranasal Delivery of Telomerase Inhibitor Grn163 , 2006 .

[46]  Phillip A Sharp,et al.  Suppression of non-small cell lung tumor development by the let-7 microRNA family , 2008, Proceedings of the National Academy of Sciences.

[47]  C. Sen,et al.  Evidence for the Involvement of miRNA in Redox Regulated Angiogenic Response of Human Microvascular Endothelial Cells , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[48]  Carme Camps,et al.  hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer , 2008, Clinical Cancer Research.

[49]  Lin Zhang,et al.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.

[50]  A. Álvarez-Buylla,et al.  Characterization of Adult Neural Stem Cells and Their Relation to Brain Tumors , 2008, Cells Tissues Organs.

[51]  Huan Yang,et al.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. , 2008, Cancer research.

[52]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.

[53]  G. I. Gallicano,et al.  Small RNAs, big potential: the role of MicroRNAs in stem cell function. , 2007, Current stem cell research & therapy.

[54]  K. Aldape,et al.  Phosphorylated Pak1 Level in the Cytoplasm Correlates with Shorter Survival Time in Patients with Glioblastoma , 2007, Clinical Cancer Research.

[55]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[56]  J. Rich,et al.  Chemotherapy and cancer stem cells. , 2007, Cell stem cell.

[57]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[58]  Ralph Weissleder,et al.  MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. , 2007, Cancer research.

[59]  I. Lorimer,et al.  Regulation of p27Kip1 by miRNA 221/222 in Glioblastoma , 2007, Cell cycle.

[60]  Giovanni Vanni Frajese,et al.  miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.

[61]  Reuven Agami,et al.  Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation , 2007 .

[62]  T. Maniatis,et al.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. , 2007, Molecular cell.

[63]  Stefanie Dimmeler,et al.  Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis , 2007, Circulation research.

[64]  B. Scheithauer,et al.  The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.

[65]  John T. Dimos,et al.  shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. , 2007, Cell stem cell.

[66]  Goberdhan P Dimri,et al.  Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. , 2007, Cancer research.

[67]  T. Golub,et al.  Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.

[68]  Jae W. Lee,et al.  The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. , 2007, Genes & development.

[69]  Jason H. Moore,et al.  Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.

[70]  M. Fraga,et al.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. , 2007, Cancer research.

[71]  T. Okamoto,et al.  NF-κB Signaling and Carcinogenesis , 2007 .

[72]  Rudolf Jaenisch,et al.  DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal , 2007, Nature Genetics.

[73]  F. Szoka,et al.  Lipid-based Nanoparticles for Nucleic Acid Delivery , 2007, Pharmaceutical Research.

[74]  N. Nikitakis,et al.  High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma , 2007, Molecular Cancer.

[75]  George A. Calin,et al.  A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.

[76]  G. Broggi,et al.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.

[77]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[78]  Thomas D. Schmittgen,et al.  Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.

[79]  H. Yee,et al.  Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion , 2006, Laboratory Investigation.

[80]  A. Grosu,et al.  Therapeutic options for recurrent high-grade glioma in adult patients: recent advances. , 2006, Critical reviews in oncology/hematology.

[81]  C. Benz,et al.  Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation. , 2006, Molecular pharmaceutics.

[82]  E. Furth,et al.  Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.

[83]  Gareth Howell,et al.  Intrinsic Tyrosine Kinase Activity is Required for Vascular Endothelial Growth Factor Receptor 2 Ubiquitination, Sorting and Degradation in Endothelial Cells , 2006, Traffic.

[84]  S. Vandenberg,et al.  PDGFRα-Positive B Cells Are Neural Stem Cells in the Adult SVZ that Form Glioma-like Growths in Response to Increased PDGF Signaling , 2006, Neuron.

[85]  M. Berger,et al.  Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. , 2006, Neuro-oncology.

[86]  Tushar Patel,et al.  Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.

[87]  Anupama E. Gururaj,et al.  p21-activated kinases in cancer , 2006, Nature Reviews Cancer.

[88]  C. Croce,et al.  MicroRNA deregulation in human thyroid papillary carcinomas. , 2006, Endocrine-related cancer.

[89]  C. Benz,et al.  Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery , 2006, Gene Therapy.

[90]  Gail Mandel,et al.  Reciprocal actions of REST and a microRNA promote neuronal identity , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[91]  Y. Doki,et al.  Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma , 2006, Gastric Cancer.

[92]  R. Plasterk,et al.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. , 2005, RNA.

[93]  Ligang Wu,et al.  Micro-RNA Regulation of the Mammalian lin-28 Gene during Neuronal Differentiation of Embryonal Carcinoma Cells , 2005, Molecular and Cellular Biology.

[94]  M. Berger,et al.  mTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme Cells , 2005, Molecular and Cellular Biology.

[95]  D. Zagzag,et al.  Angiogenesis in Gliomas: Biology and Molecular Pathophysiology , 2005, Brain pathology.

[96]  G. Maira,et al.  Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.

[97]  D. Silbergeld,et al.  TWIST is expressed in human gliomas and promotes invasion. , 2005, Neoplasia.

[98]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[99]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[100]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[101]  Lena Smirnova,et al.  Regulation of miRNA expression during neural cell specification , 2005, The European journal of neuroscience.

[102]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[103]  Shridar Ganesan,et al.  Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. , 2005, Genes & development.

[104]  S. Nelson,et al.  DNA-microarray analysis of brain cancer: molecular classification for therapy , 2004, Nature Reviews Neuroscience.

[105]  G. Semenza,et al.  Identification of hypoxia responsive genes regulated by the hypoxia inducible factor 1 (HIF-1) , 2004 .

[106]  G. Powis,et al.  Hypoxia inducible factor as a cancer drug target. , 2003, Current cancer drug targets.

[107]  A. Giaccia,et al.  HIF-1 as a target for drug development , 2003, Nature Reviews Drug Discovery.

[108]  Anthony Asher,et al.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. , 2003, Journal of neurosurgery.

[109]  P. Sharp,et al.  Embryonic stem cell-specific MicroRNAs. , 2003, Developmental cell.

[110]  William A Weiss,et al.  Genetic determinants of malignancy in a mouse model for oligodendroglioma. , 2003, Cancer research.

[111]  J. DeGregori,et al.  The genetics of the E2F family of transcription factors: shared functions and unique roles. , 2002, Biochimica et biophysica acta.

[112]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[113]  M. Schindl,et al.  Expression of hypoxia‐inducible factor–1α in oligodendrogliomas , 2001 .

[114]  N. Narita,et al.  [Suppression of non-small-cell lung carcinoma metastasis with clarithromycin]. , 2001, The Japanese journal of antibiotics.

[115]  S. Reed,et al.  Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. , 2000, Current opinion in cell biology.

[116]  G. Semenza,et al.  Expression of hypoxia‐inducible factor 1α in brain tumors , 2000 .

[117]  Eric C. Holland,et al.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice , 2000, Nature Genetics.

[118]  水松 真一郎.  Expression of cell cycle regulator p27 kip1 is correlated with survival of patients with astrocytoma , 2000 .

[119]  N. Kitamura,et al.  A Hrs binding protein having a Src homology 3 domain is involved in intracellular degradation of growth factors and their receptors , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[120]  A. Chiò,et al.  p27/kip1 expression in oligodendrogliomas and its possible prognostic role , 1999, Acta Neuropathologica.

[121]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[122]  T. Tamiya,et al.  Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[123]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[124]  M. Weller,et al.  APO2 ligand: a novel lethal weapon against malignant glioma? , 1998, FEBS letters.

[125]  D. Schiffer,et al.  p27/kip1 expression in human astrocytic gliomas , 1997, Neuroscience Letters.

[126]  V. Mukku,et al.  Regulation of epidermal growth factor receptor by estrogen. , 1985, The Journal of biological chemistry.

[127]  K. Iczkowski,et al.  MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro. , 2009, International journal of clinical and experimental pathology.

[128]  C. Brennan,et al.  glioma and facilitates gliomagenesis in vivo The PTEN-regulating microRNA miR-26 a is amplified in high-grade Material Supplemental , 2009 .

[129]  L. Aaltonen,et al.  A TARBP 2 mutation in human cancer impairs microRNA processing and DICER 1 function , 2009 .

[130]  Wei Liu,et al.  MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a , 2008, Journal of Molecular Medicine.

[131]  R. Seethala.  MicroRNA deregulation in human thyroid papillary carcinomas , 2008 .

[132]  T. Okamoto,et al.  NF-kappa B signaling and carcinogenesis. , 2007, Current pharmaceutical design.

[133]  John W. Park,et al.  Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. , 2007, Neuro-oncology.

[134]  R. Jaenisch,et al.  DGCR 8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal , 2007 .

[135]  Reuven Agami,et al.  Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. , 2007, The EMBO journal.

[136]  G. Maira,et al.  Regulation of the p 27 Kip 1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation , 2007 .

[137]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[138]  G. Powis,et al.  Hypoxia inducible factor-1alpha as a cancer drug target. , 2004, Molecular cancer therapeutics.

[139]  P. Huppert,et al.  Expression of hypoxia-inducible genes in tumor cells , 1998, Journal of Cancer Research and Clinical Oncology.

[140]  A. Kidokoro,et al.  New therapeutic approach to septic MODS , 1996 .